Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoya N Demidenko

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Cell Cycle (Georgetown, Tex.)|November 24, 2011
Rapamycin for life: a step to immortalityZoya N Demidenko
Aging|December 14, 2011
Chronological lifespan in stationary culture: from yeast to human cellsZoya N Demidenko
Aging|February 17, 2010
Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potentialZoya N Demidenko, Mikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|May 28, 2009
At concentrations that inhibit mTOR, resveratrol suppresses cellular senescenceZoya N Demidenko, Mikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|April 28, 2011
The purpose of the HIF-1/PHD feedback loop: to limit mTOR-induced HIF-1αZoya N Demidenko, Mikhail V Blagosklonny
Cancer Research|May 20, 2004
Flavopiridol induces p53 via initial inhibition of Mdm2 and p21 and, independently of p53, sensitizes apoptosis-reluctant cells to tumor necrosis factorZoya N Demidenko, Mikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|October 25, 2008
Growth stimulation leads to cellular senescence when the cell cycle is blockedZoya N Demidenko, Mikhail V Blagosklonny
Aging|January 10, 2012
Recent progress in targeting cancerZoya N Demidenko, James A McCubrey
Aging|February 22, 2013
Recent discoveries in the cycling, growing and aging of the p53 fieldJames A McCubrey, Zoya N Demidenko
FEBS Letters|April 7, 2005
Complementation of two mutant p53: implications for loss of heterozygosity in cancerZoya N Demidenko, Tito Fojo, Mikhail V Blagosklonny
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|November 24, 2011
Rapamycin for life: a step to immortalityZoya N Demidenko
Aging|December 14, 2011
Chronological lifespan in stationary culture: from yeast to human cellsZoya N Demidenko
Aging|February 17, 2010
Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potentialZoya N Demidenko, Mikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|May 28, 2009
At concentrations that inhibit mTOR, resveratrol suppresses cellular senescenceZoya N Demidenko, Mikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|April 28, 2011
The purpose of the HIF-1/PHD feedback loop: to limit mTOR-induced HIF-1αZoya N Demidenko, Mikhail V Blagosklonny
Cancer Research|May 20, 2004
Flavopiridol induces p53 via initial inhibition of Mdm2 and p21 and, independently of p53, sensitizes apoptosis-reluctant cells to tumor necrosis factorZoya N Demidenko, Mikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|October 25, 2008
Growth stimulation leads to cellular senescence when the cell cycle is blockedZoya N Demidenko, Mikhail V Blagosklonny
Aging|January 10, 2012
Recent progress in targeting cancerZoya N Demidenko, James A McCubrey
Aging|February 22, 2013
Recent discoveries in the cycling, growing and aging of the p53 fieldJames A McCubrey, Zoya N Demidenko
FEBS Letters|April 7, 2005
Complementation of two mutant p53: implications for loss of heterozygosity in cancerZoya N Demidenko, Tito Fojo, Mikhail V Blagosklonny
Pageof 4